portion is best described as an advanced administrative program. The resident may accumulate 3000 hours or so of varied pharmacy experience throughout the two years, with more administrative than clinical emphasis. The advanced clinical and administrative residencies produce graduates with advanced degrees (Pharm.D. or M.Sc.) who generally have significantly greater capabilities than do B.Sc. graduates who complete only the basic accredited residency. Considering present practice needs, all three of these programs are clearly needed to produce a composite of administrative leaders, clinical leaders and well-trained general practitioners for the nation's hospitals and other organized health care settings. Indeed, there are not nearly enough personnel being trained in residencies to achieve high quality pharmacy services in the future.
Currently, these three types of residency are only accredited under the provisions of the ASHP standards for the basic pharmacy residency in a hospital. While some of the advanced programs meet the minimum standards of die basic residency, they clearly exceed them in either clinical or administrative areas. Some good advanced· clinical residencies cannot meet the accreditation standards due to deficiencies, e.g., in dispensing, management, or sterile product preparation.
Postgraduate training in clinical pharmacy has now evolved past the level of the advanced clinical residency. Several colleges of pharmacy and teaching hospitals now offer post-Pharm.D. speciality fellowships. For example, the University of Tennessee has a fellowship (or speciality residency) in pédiatrie clinical pharmacy and the State University of New York has a fellowship in clinical pharmacokinetics. Programs have been offered in psychiatric clinical pharmacy, drug information services and family pharmacy practice. Most community hospitals do not need various specialists trained at the "fellowship" level, but they clearly need a pharmacy staff with the composite talents of the advanced administrative and clinical residents. Pharmacists trained at the specialized level are needed for clinical faculties, teaching hospitals, research centers and speciality hospitals. The quality of training at the speciality level needs to, and undoubtedly will, evolve further in the next few years. Particularly, this level of practitioner should have analytical capabilities in clinical pharmacokinetics and toxicology if a unique service is to be provided for years to come.
The future of residency training in pharmacy is taking shape, and leaders in training programs will continue the evolution with many innovations. A nagging question is what will be done about more meaningful residency accreditation standards, particularly standards for advanced administrative and clinical programs. The ASHP Task Force on Advanced Residency Training and Accreditation recommended in 1976 that standards be rapidly established for these programs, and that leaders of established programs have large input into the standard setting. Previous ASHP Councils on Clinical Pharmacy and Therapeutics have pushed for accreditation of advanced programs. An open discussion was held by the ASHP Commission on Credentialing at the recent Midyear Clinical Meeting in Atlanta. The ASHP is the most logical organization to provide the forum for leadership in advanced and speciality residency training Several thoughts should be weighed in the coming months by the Commission on Credentialing. Perhaps it is time to plan the number and location of residency training sites, so that a future standard for practice in hospitals is completion of at least a basic residency or its equivalent. The number of professional positions in hospitals will likely be quite limited in years to come, and it is important for patient welfare and the profession that high caliber pharmacists hold hospital positions. Practitioners with advanced clinical skills should be required as staff members at each residency training site if versatile practitioners are to be produced. Accreditation standards for advanced administrative and clinical residencies need to be developed soon, and long range planning to select and control the appropriate training sites needs to be undertaken. Standards for speciality programs should be aggressively studied, but action is not pressing as with the advanced programs. Action taken and plans made on these matters can greatly influence future practitioner certification, a matter which the profession needs to address in the next few years. Given the current diversity in Pharm.D. programs, the Commission should undertake a curriculum study to determine whether or not the graduates have equivalency at the basic, advanced, or speciality levels. It is not desirable that these programs be forced into mediocre standardization, only that the level of their graduates be generally determined. This knowledge would be of value to prospective Pharm.D. students and to persons seeking specific levels of competency in Pharm.D. graduates.
Pharmacy needs to avoid the mistakes made by American medicine as it overpursued specialization with resulting inadequacies in the distribution and quality of general medical care. Farsighted planning and coordination of the efforts of many innovative pharmacy practitioner/educators are necessary if the benefits of the pharmacy practice revolution of the 1960's and 1970's are to become the norm in the 1980's. DON Despite the broad scope and noble title of the AACP issue, discussion quickly deteriorated into the "one vs. two degree" question and apparently has gone little further. Never before, as during last year's AACP Annual Meeting, have I heard intelligent people, allegedly scientists, speak with such emotionalism, lack of documentation, or make such wide, sweeping statements of personal philosophy as if they were the gospel according to St. John. "Giving the pharmacist the title 'Doctor' will earn him the professional respect he deserves." "How long can we continue to cheat our students out of the best education possible?" Bunk! ! ! Seemingly no thought has been given to the multitude of questions which must be answered before one may intelligently decide the "Pharm.D.-for all" issue. What truly are the types of pharmacy personnel required to meet society's future needs? What resources are available for the education and training of pharmacy practitioners in the future? How will the pharmacist of the future earn his living as drug distribution activities receive less emphasis and clinical activities more? Will conversion to one professional degree more rapidly advance the community practice of pharmacy? Good questions, but where are the answers? People have logically turned to California, asking for proof that their system has really improved matters. They are quick to point out, however, that no data exists and that most pharmacists in the state do not have a Doctor of Pharmacy degree. Yet, the point deserves attention and study.
How could one be against the Doctor of Pharmacy as the first degree for all pharmacists? The concept has been so closely associated with the betterment of pharmacy that to oppose it is like being against motherhood, apple pie and the American flag. I would only point out that motherhood is something unavailable to 100,000,000 American males; I personally prefer pumpkin pie; and Betsy Ross did not come up with the Stars and Stripes on her first try. At this year's AACP Annual Meeting I will be asked to vote for or against converting to one degree within pharmacy. Although I am anxious to be pleasantly surprised, I do not anticipate any additional data becoming available to assist me in making a decision. I will thus be forced to decide and register my vote based primarily on emotionalism and fear, and only secondarily on logic and thought.
Consider what will likely happen if pharmacy education and practice were allowed to evolve along the paths already opened. The existent guidelines outlining Doctor of Pharmacy education will be further defined and eventually endorsed and accepted by AACP and ACPE, thus assuring (as much as possible) consistent, highly competent practitioners. As local needs become evident and resources available, more and more schools will develop doctoral programs. When the clinical pharmacist in the community truly becomes a reality, the need for additional highly trained individuals will cause Drug Intelligence and Clinical Pharmacy VOL 12 MAY 78
